Shigeyuki Chaki

Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001

Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 153 citations · Full text

Medicine, Neuroscience, Pharmacology +15

5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices

Makoto Muramatsu, Junko Tamaki-Ohashi, Chika Usuki et al. · European Journal of Pharmacology · 1988 · 63 citations

Life Sciences, Neuroscience, Pharmacology +17

A selective dopamine D4 receptor antagonist, NRA0160: A preclinical neuropharmacological profile

Shigeru Okuyama, Naoya Kawashima, Shigeyuki Chaki et al. · Life Sciences · 1999 · 28 citations

Medicine, Neuroscience, Pharmacology +14

In Vitro and In Vivo Characterization of the Dopamine D4 Receptor, Serotonin 5-HT2AReceptor and Alpha-1 Adrenoceptor Antagonist (R)-(+)-2-Amino-4-(4-Fluorophenyl)- 5-[1-[4-(4-Fluorophenyl)-4-Oxobutyl]Pyrrolidin-3-yl]Thiazole (NRA0045)

Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +14